ICU Medical Voluntarily Recalls Lots of Potassium Chloride Injection Bags

Recently, ICU Medical, Inc. voluntarily recalled certain lots of potassium chloride injection bags with overwrap labels. This came after a customer complaint was received that Potassium Chloride Inj. Bags that had overlap labels of 20 mEq, which incorrectly identify the bag as Potassium Chloride Inj. 10mEq. This mislabeling has the potential to cause harm. If you were harmed due to improperly labeled potassium chloride, you should call the seasoned Chicago-based lawyers of Moll La Group to determine your legal options. Billions have been recovered in cases with which we’ve been involved around the country.

Contact Moll Law Group About a Potassium Chloride Claim

The manufacturer has recalled certain batches of Potassium Chloride due to the possibility of mislabeling on product overwraps so that certain units are identified as 10 mEq instead of 20 mEq. When that incorrect overwrap is in place, the correct 20 mEq label fixed to the bag can’t be seen easily. This can cause serious problems.

If a health care provider calculates the patient’s dose of the medication using the 10mEq label, the patient will get an intravenous overdose of potassium chloride. This can lead to problems like death from cardiac arrest, dysrhythmias, hypotension, confusion, and neuromuscular dysfunction such as ascending paralysis, vertigo, mental confusion and vertigo. Various groups are at real risk for adverse or even fatal consequences; these groups include premature infants, patients who have had cardiac arrhythmia, patients who have had chronic renal insufficiency or acute renal failure, and patients on chronic  parenteral nutrition. However, it should be noted that there haven’t been reports of adverse events due to the mislabeling thus far.

Doctors use Potassium Chloride Injection 10 mEq and 20 mEq to treat potassium deficiency when it’s not possible to take it orally. These are packaged in 100 ml bags. The mislabeling on the overwrap can be dangerous. It says NDC 0990-7074-26, 200 mEq/L POTASSIUM CHLORIDE In. 10mEq. The bags are packaged in cases marked NDC 0990-7075-26, CASE PACK 1×24 – 100ML 20MEQ POTASSIUM CHLORIDE INJECTION LOT NO. 1023172, EXP DATE 2026-01.

It may be appropriate to pursue damages against the manufacturer in a product liability lawsuit, if you were treated with an incorrectly wrapped Potassium Chloride injection and suffered harm as a result. Product liability lawsuits can be brought when a product, such as a treatment, is defective in terms of its marketing, manufacturing, or design. Often, cases in which there has been a mislabeling of a pharmaceutical, there is a marketing defect. When our lawyers are able to establish liability, we may be able to recover compensatory damages, or damages intended to make you whole again.

When a doctor fails to attend to a manufacturer’s recall or other warnings of mislabeling and this failure falls below the professional standard of care applicable to similar doctors, he or she can be held accountable under a theory of medical malpractice.

If you were harmed by an incorrect potassium chloride injection, you may have grounds to sue the manufacturer, and perhaps in some cases, the medical provider, for damages. Our law firm represents injured plaintiffs across the country. Please call our experienced Chicago-based product liability attorneys about your legal options. Complete our online form or by calling us at 312.462.1700.